Browsing by Author Hughes, Timothy P.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 2 of 2
Issue DateTitleAuthor(s)
9-Mar-2017Long-term outcomes of imatinib treatment for chronic myeloid leukemia.Hochhaus, Andreas; Larson, Richard A.; Guilhot, François; Radich, Jerald P.; Branford, Susan; Hughes, Timothy P.; Baccarani, Michele; Deininger, Michael W.; Cervantes Requena, F.; Fujihara, Satoko; Ortmann, Christine E.; Menssen, Hans D.; Kantarjian, Hagop M.; O'Brien, Stephen G.; Druker, Brian J.
5-Feb-2014Safety and efficacy of switching to nilotinib 400 mg twice daily for patients with chronic myeloid leukemia in chronic phase with suboptimal response or failure on frontline imatinib or nilotinib 300 mg twice daily.Hughes, Timothy P.; Hochhaus, Andreas; Kantarjian, Hagop M.; Cervantes Requena, F.; Guilhot, François; Niederwieser, Dietger; le Coutre, Philipp D.; Rosti, Gianantonio; Ossenkoppele, Gert J.; Lobo, Clarisse; Shibayama, Hirohiko; Fan, Xiaolin; Menssen, Hans D.; Kemp, Charisse; Larson, Richard A.; Saglio, Giuseppe